QLabs

What QLabs does

QLabs, Inc. is a private clinical reference laboratory headquartered in Charleston, West Virginia, founded in 2004. The company provides a multi-modality diagnostic testing portfolio anchored in urine toxicology (LC/MS/MS methodology covering 70+ analytes for pain management, employer, and forensic use), multiplex PCR molecular diagnostics across respiratory, gastrointestinal, urinary, wound, nail, dermatological, and STI indications, routine blood testing, and next-generation-sequencing-based non-invasive prenatal screening (AssurePS and AssurePlus). The wholly-owned QPath division extends the business into dermatopathology with a digital pathology platform offering EMR integration and expert second opinions.

The company operates a hybrid distribution model consisting of three owned Patient Care Centers in West Virginia (Charleston, Bluefield, and Logan) for direct patient access, and a B2B channel serving healthcare providers, employers, and criminal justice agencies across approximately 13 states, with criminal justice support extending nationwide. Logistics are supported by FedEx and UPS integrations with UN3373-compliant specimen shipping, and patient/provider result delivery is enabled through the CareEvolve portal.

QLabs generates revenue primarily through fee-for-service laboratory testing paid via insurance reimbursement, direct patient self-pay (which the company markets as often more favorable than deductibles or co-pays), and enterprise contracts with employer workplace testing programs (DOT and non-DOT) and criminal justice agencies. The company positions itself on turnaround time (72 hours or less for toxicology, 24–48 hours for PCR), methodological accuracy (95–100% sensitivity / 97–99% specificity across major PCR panels), and self-emphasized 'industry low pricing' as competitive differentiators against larger national reference labs.

Name

QLabs

Legal name

QLabs, Inc.

Website

https://qlabs-inc.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

QLabs is a Charleston, WV-based clinical reference laboratory providing urine toxicology (LC/MS/MS), multiplex PCR molecular diagnostics, blood testing, non-invasive prenatal screening, and dermatopathology (via QPath) to healthcare providers, employers, criminal justice agencies, and individual patients across 13 states.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Clinical laboratory testing
• Molecular diagnostics
• Toxicology screening
• Workplace drug testing
• Pathology services

Headquarters

HQ city

Charleston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: QLabs generates revenue through fee-for-service laboratory testing across multiple categories including toxicology/drug testing, blood testing, PCR molecular diagnostics, and pathology services. Revenue is derived from insurance reimbursements, direct patient payments (self-pay), and contractual arrangements with healthcare providers, employers, and criminal justice agencies. The company offers transparent pricing for self-pay patients and works with all insurance providers.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

QLabs, Inc. is a medical laboratory that provides a comprehensive range of diagnostic testing services including molecular diagnostic PCR testing across multiple specialties (respiratory, gastrointestinal, urinary tract, wound, nail, dermatological, and sexually transmitted infections), comprehensive urine toxicology/drug testing using LC/MS/MS, blood testing, and non-invasive prenatal screening (AssurePS/AssurePlus) using next-generation sequencing. Through its QPath division, QLabs offers specialized dermatopathology services including digital pathology, EMR integration, and consensus reviews.

Product overview

QLabs is a medical laboratory headquartered in Charleston, WV, providing a comprehensive portfolio of diagnostic testing services across clinical healthcare, employer workplace, and criminal justice sectors. The core offering consists of molecular diagnostic PCR testing across multiple specialty areas (respiratory, gastrointestinal, urinary, wound, nail, dermatological, and sexual health), comprehensive toxicology urine drug testing (both DOT-regulated and non-DOT panels), blood testing services, and non-invasive pregnancy screening using next-generation sequencing (AssurePS and AssurePlus). The subsidiary division QPath provides specialized dermatopathology services with digital pathology capabilities. QLabs operates Patient Care Centers in Bluefield, Charleston, and Logan, WV, and extends laboratory services across approximately 13 states with nationwide criminal justice support. The company emphasizes rapid turnaround times, cutting-edge molecular technology, and specialized expertise for healthcare providers, employers, and criminal justice professionals.

Differentiator

Problem solved

Functional benefit

Brands

• QPath: A division of QLabs, Inc. providing state-of-the-art dermatopathology lab services, specializing in skin pathology diagnostics with digital pathology platform, EMR integration, and second opinions & consensus reviews.

Products and services

• Respiratory PCR Testing PCR testing for respiratory pathogens including bacteria, viruses, and fungi using nasopharyngeal swabs, with sensitivity rates of 95-100% and specificity rates of 97-99%. Designed for healthcare providers diagnosing respiratory infections.
• Gastrointestinal Infection PCR Testing PCR testing for gastrointestinal infections to identify bacterial, viral, and parasitic pathogens in stool samples with enhanced detection sensitivity and results delivered within 24 to 48 hours.
• Infectious Disease PCR Testing Molecular diagnostic PCR testing for identifying bacterial, viral, and parasitic pathogens with exceptional precision, delivering results within 24 to 48 hours for healthcare professionals across 13 states.
• Urinary Tract Infection (UTI) PCR Testing PCR testing for urinary tract infections using molecular diagnostics to identify bacteria at the molecular level with greater accuracy and faster results than traditional culture methods, with sensitivity rates of 95-98% and specificity rates of 97-99%.
• Sexually Transmitted Infections (STI) PCR Testing PCR testing for detecting STIs including chlamydia, gonorrhea, trichomoniasis, and HPV, with standard STI panel testing for HIV, syphilis, and hepatitis. Sensitivity rates over 95% and specificity rates over 98%.
• Wound PCR Testing PCR testing for wound infections detecting bacteria, fungi, and viruses with sensitivity rates of 94-97% and specificity rates of 95-98% for medical providers.
• Nail PCR Testing PCR testing for fungal nail infections detecting dermatophytes, yeasts, and molds with sensitivity rates of 90-95% and specificity rates of 96-99% for medical providers.
• Dermatological PCR Testing PCR testing for dermatological pathogens including bacteria, viruses, and fungi with sensitivity rates of 90-98% and specificity rates of 95-99% for medical providers.
• Blood Testing Services Comprehensive blood testing services including glucose testing, lipid profiles, thyroid function tests, and routine screenings for diagnosing and monitoring health conditions, available to patients and healthcare providers.
• Toxicology Testing (Urine LC/MS/MS) Comprehensive urine toxicology testing using LC/MS/MS methodology covering over 80 analytes including opioids, benzodiazepines, antidepressants, stimulants, and synthetic opioids, with pain management panels and 72-hour or less turnaround time.
• DOT Drug Testing Department of Transportation compliant drug testing including pre-employment, random, post-accident, and return-to-duty testing with MRO review and breathalyzer testing for employers and transportation industry compliance.
• Non-DOT 12 Panel Drug Testing Presumptive and definitive urine and oral fluid drug testing panel covering 12 substance categories including COC, AMP, METH, OPI, MDMA, BAR, BZO, EDDP, OXY, 6-MAM, FENT, with THC as optional add-on for employers and criminal justice agencies.
• Clinical Laboratory Services Clinical laboratory services serving healthcare professionals across multiple settings with comprehensive diagnostic solutions and electronic results reporting.
• AssurePS (Non-Invasive Pregnancy Screening) Non-invasive prenatal screening using next-generation sequencing technology to detect chromosomal aneuploidies including Trisomy 21 (Down syndrome), Trisomy 18, and Trisomy 13 as early as 10 weeks gestation, with a low failure rate of 0.6%.
• AssurePlus (Expanded Non-Invasive Pregnancy Screening) Expanded prenatal screening panel offering rare autosomal trisomies and clinically significant microdeletions beyond common trisomy screenings using next-generation sequencing from a single blood draw.
• QPath Dermatopathology Services State-of-the-art dermatopathology laboratory division offering skin pathology diagnostics, EMR integration, second opinions, and consensus reviews by board-certified dermatopathologists.

Quantifiable outcome

• PCR testing sensitivity rates of 95-98% and specificity rates of 97-99% for detecting common uropathogens
• +6 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature7 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• ARUP Laboratories: National reference laboratory affiliated with the University of Utah offering highly specialized molecular diagnostics, toxicology, and pathology. Comparable breadth of esoteric and routine testing menu with strong hospital/professional services channel.
• PathGroup: Regional pathology and clinical laboratory serving the Southeast US with molecular diagnostics, toxicology, and dermatopathology services. Comparable scale and geographic model to QLabs, including employer and criminal justice testing exposure.
• BioReference Laboratories (OPKO Health): Specialty clinical laboratory offering molecular diagnostics, women's health/NIPS, toxicology, and pathology services. Closely comparable mix of multiplex PCR panels and NIPT to QLabs, with similar exposure to payer reimbursement dynamics.
• Sonic Healthcare USA: International diagnostic laboratory operator with US presence (including Pathology Associates and Sunrise Medical Labs) offering molecular diagnostics, toxicology, and pathology. Closely comparable specialty lab model with mix of regional clinical labs and specialized testing divisions.

Regional players

• CompuNet Clinical Laboratories: Regional clinical laboratory based in the Midwest offering molecular diagnostics, toxicology, and pathology to healthcare providers and employers. Comparable regional lab model to QLabs' West Virginia-anchored footprint.

Broad incumbents

• Quest Diagnostics: Largest US clinical laboratory network offering PCR molecular diagnostics, toxicology, blood testing, and NIPS nationwide. Operates thousands of patient service centers and has substantially greater payer leverage, scale, and automation investment than QLabs.
• Genomic Health (Exact Sciences): Molecular diagnostics company offering Oncotype DX and broader cancer screening tests through a national commercial channel. Comparable molecular diagnostic platform capability though focused on oncology rather than infectious disease or toxicology.
• Laboratory Corporation of America (LabCorp): National reference laboratory with deep molecular diagnostics, toxicology, women's health/NIPT (through Integrated Genetics), and pathology offerings. Competes with QLabs across virtually every service line but at materially larger scale and broader geographic footprint.
• Eurofins Scientific: Global testing laboratory group with US clinical diagnostics operations covering molecular diagnostics, toxicology, and specialty testing. Comparable comprehensive testing menu with substantially greater international scale and automation investment.

Emerging players

• Natera: Molecular diagnostics company specializing in non-invasive prenatal testing (Panorama), oncology, and organ transplant monitoring. Directly comparable to QLabs' AssurePS/AssurePlus NIPS offering but with a national specialty focus rather than regional clinical lab model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QLabs